Potentially Fatal Adverse Allergic Events to Intravenous Thrombolytics: An Analysis from Adverse Event Reporting System

被引：0
|
作者：
Khan, Asif [1 ]
Zarar, Amna [2 ]
Adil, Malik [3 ]
Qureshi, Adnan [3 ]
机构：
[1] Zeenat Qureshi Stroke Res Ctr, St Louis Pk, MN USA
[2] Zeenat Qureshi Stroke Res Ctr, Minnepolis, MN USA
[3] Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN USA
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Potentially Fatal Adverse Allergic Events to Intravenous Thrombolytics: An analysis from Adverse Event Reporting System
    Khan, Asif A.
    Zarar, Amna
    Adil, Malik M.
    Qureshi, Adnan I.
    [J]. STROKE, 2013, 44 (02)
  • [2] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [3] Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
    Rafaniello, Concetta
    Ferrajolo, Carmen
    Sullo, Maria Giuseppa
    Gaio, Mario
    Zinzi, Alessia
    Scavone, Cristina
    Gargano, Francesca
    Coscioni, Enrico
    Rossi, Francesco
    Capuano, Annalisa
    [J]. PHARMACEUTICALS, 2021, 14 (07)
  • [4] Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
    Matthew S. Duprey
    Nada S. Al-Qadheeb
    Nick O’Donnell
    Keith B. Hoffman
    Jonathan Weinstock
    Christopher Madias
    Mo Dimbil
    John W. Devlin
    [J]. Drugs - Real World Outcomes, 2019, 6 : 141 - 149
  • [5] Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
    Duprey, Matthew S.
    Al-Qadheeb, Nada S.
    O'Donnell, Nick
    Hoffman, Keith B.
    Weinstock, Jonathan
    Madias, Christopher
    Dimbil, Mo
    Devlin, John W.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2019, 6 (03) : 141 - 149
  • [6] Adverse events and adverse event reporting systems
    Huebler, M.
    Moellemann, A.
    Metzler, H.
    Koch, T.
    [J]. ANAESTHESIST, 2007, 56 (10): : 1067 - +
  • [7] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [8] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    [J]. BMC Pharmacology and Toxicology, 24
  • [9] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    [J]. MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [10] Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Xiong, Xiaomei
    Zhang, Xiuwen
    Li, Xiaoxia
    Huang, Taomin
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
12345